Science & Technology

Corporate Office

VANCOUVER, B.C. CANADA

Facility Location

SOUTHEAST QUEENSLAND AUSTRALIA

Facility Size

51 HECTARES/125 ACRES

Projected Capacity

537,500 KG/ANNUM

Asterion has entered into a collaborative research contract with the Queensland Alliance for Agriculture and Food Innovation (“QAAFI”) at the University of Queensland consisting of an eighteen month, ‘proof-of-concept’ clonal propagation research program. 

The aim will be to expedite clonal propagation of elite selections of cannabis plants to enable high volume, uniform plant cultivation that will be required to serve the rapidly growing demand for cannabis-based medicines for a wide and expanding variety of ailments. The outcome will develop proof of concept for in vitro propagation of the selected cultivars.  

The research will identify and establish a proprietary, genetically stable, repeatable, high yield tissue propagation procedure for a number of cannabis strains.  The use of tissue culture will provide a pathogen-free source of stable genetics, eliminating the need for mothers and manual cloning procedures.  The intellectual property generated through the research will be wholly owned by Asterion, creating a suite of technologies and procedures absolutely necessary for large scale cannabis facilities.   

April 9, 2020

Asterion Appoints Amy Stephenson as Chief Investment Officer

arrowRead More
March 31, 2020

Asterion Signs DAA for $400 Million

arrowRead More
March 9, 2020

Asterion Cannabis to Participate in the 32nd Annual ROTH Conference

arrowRead More

arrowView All News

Stay up to date with our latest news:

What are you searching for?

Stay up to date with our latest news:

Sign up to receive updates
Are you of legal age in your province or territory of residence?